Timothy Plan US Large/Mid Cap Core ETF

48.35

+0.97002.05%

Post-market: 48.350.00000.00%16:48 EST

Volume:14.89K

Turnover:717.58K

Market Cap:347.49M

PE:- -

High:48.35

Open:47.80

Low:47.80

Close:47.38

52wk High:48.35

52wk Low:37.15

Shares:7.19M

Float Shares:7.19M

Volume Ratio:0.61

T/O Rate:0.21%

Dividend:0.41

Dividend Rate:0.85%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

GlobeNewswire

·

Oct 21, 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TPLC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TPLC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TPLC\",,,,,undefined,":{"symbol":"TPLC","market":"US","secType":"STK","nameCN":"Timothy Plan US Large/Mid Cap Core ETF","latestPrice":48.35,"timestamp":1770411600000,"preClose":47.38,"halted":0,"volume":14892,"hourTrading":{"tag":"盘后","latestPrice":48.35,"preClose":48.35,"latestTime":"16:48 EST","volume":35,"amount":1687.11,"timestamp":1770414517309,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0204727733220768,"floatShares":7187008,"shares":7187008,"eps":0,"marketStatus":"Market Closed","change":0.97,"latestTime":"02-06 16:00:00 EST","open":47.8,"high":48.35,"low":47.8,"amount":717578.338383,"amplitude":0.011608,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":47.38,"sharesOutstanding":7187008,"nav":47.411035,"aum":340743236.29,"dividendRate":0.008525,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":48.35,"preClose":48.35,"latestTime":"16:48 EST","volume":35,"amount":1687.11,"timestamp":1770414517309,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6135552246157873},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TPLC\",,,,,undefined,":{"symbol":"TPLC","floatShares":7187008,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6135552246157873,"shares":7187008,"dividePrice":0.4122,"high":48.35,"amplitude":0.011608,"preClose":47.38,"low":47.8,"week52Low":37.15,"pbRate":"--","week52High":48.35,"institutionHeld":0,"latestPrice":48.35,"eps":0,"divideRate":0.008525,"volume":14892,"delay":0,"ttmEps":0,"open":47.8,"prevYearClose":45.45,"prevWeekClose":47.14,"prevMonthClose":47.14,"prevQuarterClose":45.45,"fiveDayClose":47.14,"twentyDayClose":46.63,"sixtyDayClose":45.72},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TPLC\",params:#limit:5,,,undefined,":[{"date":"2026-01-08","symbol":"TPLC","amount":0.014304,"announcedDate":"2026-01-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-08","defaultRemindTime":1767882600000,"name":"Timothy Plan US Large/Mid Cap Core ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-09","payableDate":"2026-01-08","currency":"USD","dateTimestamp":1767848400000,"payDate":"2026-01-09"},{"date":"2025-12-11","symbol":"TPLC","amount":0.075645,"announcedDate":"2025-12-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-11","defaultRemindTime":1765463400000,"name":"Timothy Plan US Large/Mid Cap Core ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-12","payableDate":"2025-12-11","currency":"USD","dateTimestamp":1765429200000,"payDate":"2025-12-12"},{"date":"2025-11-07","symbol":"TPLC","amount":0.008655,"announcedDate":"2025-11-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-07","defaultRemindTime":1762525800000,"name":"Timothy Plan US Large/Mid Cap Core ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-10","payableDate":"2025-11-07","currency":"USD","dateTimestamp":1762491600000,"payDate":"2025-11-10"},{"date":"2025-10-09","symbol":"TPLC","amount":0.027473,"announcedDate":"2025-10-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-09","defaultRemindTime":1760016600000,"name":"Timothy Plan US Large/Mid Cap Core ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-10","payableDate":"2025-10-09","currency":"USD","dateTimestamp":1759982400000,"payDate":"2025-10-10"},{"date":"2025-09-08","symbol":"TPLC","amount":0.065146,"announcedDate":"2025-09-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-08","defaultRemindTime":1757338200000,"name":"Timothy Plan US Large/Mid Cap Core ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-09-08","currency":"USD","dateTimestamp":1757304000000,"payDate":"2025-09-09"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TPLC\",market:\"US\",,,undefined,":[{"executeDate":"2019-06-13","recordDate":"2019-06-14","paymentDate":"2019-06-17","value":0.032353,"currency":"USD"},{"executeDate":"2019-07-17","recordDate":"2019-07-18","paymentDate":"2019-07-19","value":0.024048,"currency":"USD"},{"executeDate":"2019-08-14","recordDate":"2019-08-15","paymentDate":"2019-08-16","value":0.007178,"currency":"USD"},{"executeDate":"2019-09-10","recordDate":"2019-09-11","paymentDate":"2019-09-12","value":0.037912,"currency":"USD"},{"executeDate":"2019-11-13","recordDate":"2019-11-14","paymentDate":"2019-11-15","value":0.01144,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TPLC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TPLC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2477852987","title":"Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme","url":"https://stock-news.laohu8.com/highlight/detail?id=2477852987","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477852987?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:30","pubTimestamp":1729513800,"startTime":"0","endTime":"0","summary":"JERUSALEM, Oct.  21, 2024  (GLOBE NEWSWIRE) --  Alpha Tau Medical Ltd. (\"Alpha Tau\", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha DaRT, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/21/2966203/0/en/Alpha-Tau-Announces-Acceptance-Into-FDA-s-Total-Product-Life-Cycle-Advisory-Program-to-Accelerate-Market-Access-to-Alpha-DaRT-for-Patients-with-Recurrent-Glioblastoma-Multiforme.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPLC","DRTS","TSS","AAQC","BK4082"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TPLC\",params:#limit:6,delay:false,,,undefined,":[]}}